» Articles » PMID: 17440034

Adipose Tissue Distribution in Relation to Insulin Resistance in Type 2 Diabetes Mellitus

Overview
Date 2007 Apr 19
PMID 17440034
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Insulin resistance (IR) is typically more severe in obese individuals with type 2 diabetes (T2DM) than in similarly obese non-diabetics but whether there are group differences in body composition and whether such differences contribute to the more severe IR of T2DM is uncertain. DEXA and regional CT imaging were conducted to assess adipose tissue (AT) distribution and fat content in liver and muscle in 67 participants with T2DM (F39/M28, age 60 +/- 7 yr, BMI 34 +/- 3 kg/m(2)) and in 35 similarly obese, non-DM volunteers (F20/M15, age 55 +/- 8 yr, BMI 33 +/- 2 kg/m(2)). A biopsy of subcutaneous abdominal AT was done to measure adipocyte size. A glucose clamp was performed at an insulin infusion of 80 mU x min(-1) x m(-2). There was more severe IR in T2DM (6.1 +/- 2.3 vs. 9.9 +/- 3.3 mg x min(-1) x kg FFM(-1); P < 0.01). Group comparisons of body composition parameters was performed after adjusting for the effect of age, gender, race, height and total fat mass (FM). T2DM was associated with less leg FM (-1.2 +/- 0.4 kg, P < 0.01), more trunk FM (+1.1 +/- 0.4 kg, P < 0.05), greater hepatic fat (P < 0.05), and more subfascial adipose tissue around skeletal muscle (P < 0.05). There was a significant group x sex interaction for VAT (P < 0.01), with greater VAT in women with T2DM (P < 0.01). Mean adipocyte size (AS) did not significantly differ across groups, and smaller AS was associated with increased leg FM, whereas larger AS was related to more trunk FM (both P < 0.05). Group differences in IR were less after adjusting for group differences in leg FM, trunk FM, and hepatic fat, but these adjustments only partially accounted for the greater severity of IR in T2DM. In summary, T2DM, compared with similarly obese nondiabetic men and women, is associated with less leg FM and greater trunk FM and hepatic fat.

Citing Articles

The relationship between fat distribution and diabetes in US adults by race/ethnicity.

Xu F, Earp J, Riebe D, Delmonico M, Lofgren I, Greene G Front Public Health. 2024; 12:1373544.

PMID: 38450122 PMC: 10916687. DOI: 10.3389/fpubh.2024.1373544.


The size of human subcutaneous adipocytes, but not adiposity, is associated with inflammation, endoplasmic reticulum stress, and insulin resistance markers.

Pourdashti S, Faridi N, Monem-Homaie F, Yaghooti S, Soroush A, Bathaie S Mol Biol Rep. 2023; 50(7):5755-5765.

PMID: 37219669 PMC: 10289932. DOI: 10.1007/s11033-023-08460-y.


FABP4 Controls Fat Mass Expandability (Adipocyte Size and Number) through Inhibition of CD36/SR-B2 Signalling.

Berger E, Geloen A Int J Mol Sci. 2023; 24(2).

PMID: 36674544 PMC: 9867004. DOI: 10.3390/ijms24021032.


Unpacking determinants and consequences of food insecurity for insulin resistance among people living with HIV: Conceptual framework and protocol for the NOURISH-OK study.

Wetherill M, Bakhsh C, Caywood L, Williams M, Hartwell M, Wheeler D Front Clin Diabetes Healthc. 2022; 3.

PMID: 36225538 PMC: 9552993. DOI: 10.3389/fcdhc.2022.947552.


Insulin prevents fatty acid induced increase of adipocyte size.

Berger E, Geloen A Adipocyte. 2022; 11(1):510-528.

PMID: 35946137 PMC: 9450899. DOI: 10.1080/21623945.2022.2107784.


References
1.
Harris R, Ramsay T, Smith S, Bruch R . Early and late stimulation of ob mRNA expression in meal-fed and overfed rats. J Clin Invest. 1996; 97(9):2020-6. PMC: 507275. DOI: 10.1172/JCI118637. View

2.
Bjorntorp P . Regional fat distribution--implications for type II diabetes. Int J Obes Relat Metab Disord. 1992; 16 Suppl 4:S19-27. View

3.
Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M . Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001; 50(8):1844-50. DOI: 10.2337/diabetes.50.8.1844. View

4.
Goodpaster B, Thaete F, Simoneau J, Kelley D . Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes. 1997; 46(10):1579-85. DOI: 10.2337/diacare.46.10.1579. View

5.
Ryysy L, Hakkinen A, Goto T, Vehkavaara S, Westerbacka J, Halavaara J . Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes. 2000; 49(5):749-58. DOI: 10.2337/diabetes.49.5.749. View